ClinicalTrials HQ

Lomustine in Addition to Standard of Care in Patients With MGMT Methylated Glioblastoma

Lomustine in Addition to Standard of Care in Patients With MGMT Methylated Glioblastoma

Recruiting · NCT06419946 · Registry updated 2026-04-13
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Lomustine in Addition to Standard of Care in Patients With MGMT Methylated GlioblastomaNeoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, astrocytoma (excluding glioblastoma), epithelial neoplasm, glioblastoma, glioma, neoplasm, neuroepithelial neoplasm, primitive neuroectodermal tumorRecruitingPhase 32026-04-13NCT06419946

21 results · Page 1 of 1

20 results · Page 1 of 1

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Aarhus University HospitalAarhusDenmark77
Gävle HospitalGävleSweden12
Haukeland University HospitalBergenNorway52
Kalmar Country HospitalKalmarSweden1
Karolinska InstitutetStockholmSweden32
Kepler University HospitalLinzAustria6
Medizinische Universität InnsbruckInnsbruckAustria8
Norrlands Universitetssjukhus, Umea, SwedenUmeåSweden1
Oslo University HospitalOsloNorway111
Ryhov County HospitalJönköpingSweden5
Sahlgrenska University HospitalGothenburgSweden96
Skåne University HospitalLundSweden39
Sorlandet SykehusKristiansandNorway1
St Olavs HospitalTrondheimNorway21
Stavanger University HospitalStavangerNorway36
Sundsvall HospitalSundsvallSweden8
University Hospital GrazGrazAustria1
University Hospital St. PöltenSankt PöltenAustria2
Uppsala University HospitalUppsalaSweden50
Örebro University HospitalÖrebroSweden40